HBRS Anniversary Brochure (2010)

Total Page:16

File Type:pdf, Size:1020Kb

HBRS Anniversary Brochure (2010) HBRS Hannover Biomedical Research School Research Biomedical Hannover Jubiläumsbericht 2010 Anniversary Report Jubiläumsbericht Jubiläumsbericht 2009 | Anniversary Report Hannover Biomedical Research School Dean: Coordination office: Prof. Dr. Reinhold E. Schmidt Dr. Susanne Kruse and Marlies Daniel Department of Immunology MHH – OE 9117 and Rheumatology Carl-Neuberg Str. 1 30625 Hannover [email protected] Germany Hannover Biomedical 2010 Tel. +49 511 532-6011 Research School [email protected] Cluster of Excellence www.rebirth-hannover.de 2010 Jubiläumsbericht Anniversary Report Hannover Biomedical Research School Inhaltsverzeichnis HBRS Table of Contents Vorwort des Präsidenten der MHH 4 Department of Molecular Hematopoiesis 90 Vorwort des Dekans der HBRS 6 Institute of Pathology 92 Vorwort des niedersächsischen Ministerpräsidenten 8 Department of Pediatric Hematology and Oncology 94 Department of Pediatric Pulmonology, Allergology Die HBRS und ihre Programme 11 and Neonatology 96 Unter dem Dach der HBRS 12 Institute of Pharmacology 98 Förderung durch die Exzellenzinitiative 14 Institute of Physiological Chemistry 100 Best Practice an der MHH 16 Department of Pneumology 102 Vom Jahr 2000 bis heute 18 Institute of Toxicology 104 Internationaler Wissenschaftlicher Beirat 20 Institute of Transfusion Medicine 106 Studenten und Karrieren 22 Institute of Virology 108 Auswahl, Zugang, Abschlüsse 26 TWINCORE Profil der Programme 28 Translational Research Group Cell and Gene Therapy 110 Stellen, Stipendien, Soziale Benefits 34 Institute of Experimental Infection Research 112 Von Summer School bis Soft Skills 36 Department of Experimental Virology 114 Mit Personalentwicklung up to date 38 Institute of Infection Immunology 116 Department of Pathophysiology of Bacterial Biofilms 118 Beteiligte Institutionen 41 HZI Kurzbeschreibungen der Institutionen 42 Department of Cell Biology 120 MHH Department of Experimental Immunology 122 Department of Anesthesiology and Intensive Care Medicine 48 Department of Gene Regulation and Differentiation 124 Institute of Biophysical Chemistry 50 Department of Infection Genetics 126 Department of Cardiology and Angiology 52 Department of Molecular Infection Biology 128 Department of Cardiothoracic, Transplantation and Department of Vaccinology and Applied Microbiology 130 Vascular Surgery 54 ITEM Institute of Cell and Molecular Pathology 56 Institute of Cell Biology 58 Department of Immunology, Allergology and Immunotoxicology 132 Institute of Cellular Chemistry 60 LUH Department of Dermatology, Allergy and Venereology 62 Institute of Inorganic Chemistry / AG Solid and Material Chemistry 134 Department of Experimental Hematology 64 Laser Zentrum Hannover / AG Biophotonics 136 Institute of Functional and Applied Anatomy 66 Institute of Multiphase Processes 138 Department of Gastroenterology, Hepatology and Endocrinology 68 TiHo Department of General, Viszeral and Transplantation Surgery 70 Institute of Microbiology / Department of Infectious Diseases Department of Hematology, Hemostasis, Oncology 140 and Stem Cell Transplantation 72 MPI Institute of Human Genetics 74 Department of Cell and Developmental Biology / Institute of Immunology 76 JRG Stem Cell Biology 142 Department of Immunology and Rheumatology 78 FLI Institute of Laboratory Animal Science 80 Institute of Farm Animal Genetics 144 Institute of Medical Microbiology and Hospital Epidemiology 82 Institute of Molecular and Cell Physiology 84 Listen der aktuellen HBRS Studenten 147 Institute of Molecular and Translational Therapeutic Strategies 86 Listen der ehemaligen Studenten 151 Institute of Molecular Biology 88 Impressum 156 2 | Jubiläumsbericht HBRS | A Word from the President of MHH 5 Department of Molecular Hematopoiesis 90 A Word from the Dean of HBRS 7 Institute of Pathology 92 A Word from the Prime Minister of Lower Saxony 9 Department of Pediatric Hematology and Oncology 94 Department of Pediatric Pulmonology, Allergology The HBRS and its Programs 11 and Neonatology 96 Under the Auspices of HBRS 12 Institute of Pharmacology 98 Support by the Excellence Initiative 14 Institute of Physiological Chemistry 100 Best Practice at MHH 16 Department of Pneumology 102 From the Year 2000 up to Today 18 Institute of Toxicology 104 International Advisory Board 20 Institute of Transfusion Medicine 106 Students and Careers 22 Institute of Virology 108 Selection, Requirements, Final Degrees 26 TWINCORE Program Profile 28 Translational Research Group Cell and Gene Therapy 110 Positions, Stipends, Social Benefits 34 Institute of Experimental Infection Research 112 From Summer School to Soft Skills 36 Department of Experimental Virology 114 With Staff Development up to date 38 Institute of Infection Immunology 116 Department of Pathophysiology of Bacterial Biofilms 118 Partner Institutions 41 HZI Brief Description of the Institutions 42 Department of Cell Biology 120 MHH Department of Experimental Immunology 122 Department of Anesthesiology and Intensive Care Medicine 48 Department of Gene Regulation and Differentiation 124 Institute of Biophysical Chemistry 50 Department of Infection Genetics 126 Department of Cardiology and Angiology 52 Department of Molecular Infection Biology 128 Department of Cardiothoracic, Transplantation and Department of Vaccinology and Applied Microbiology 130 Vascular Surgery 54 ITEM Institute of Cell and Molecular Pathology 56 Institute of Cell Biology 58 Department of Immunology, Allergology and Immunotoxicology 132 Institute of Cellular Chemistry 60 LUH Department of Dermatology, Allergy and Venereology 62 Institute of Inorganic Chemistry / AG Solid and Material Chemistry 134 Department of Experimental Hematology 64 Laser Zentrum Hannover / AG Biophotonics 136 Institute of Functional and Applied Anatomy 66 Institute of Multiphase Processes 138 Department of Gastroenterology, Hepatology and Endocrinology 68 TiHo Department of General, Viszeral and Transplantation Surgery 70 Institute of Microbiology / Department of Infectious Diseases Department of Hematology, Hemostasis, Oncology 140 and Stem Cell Transplantation 72 MPI Institute of Human Genetics 74 Department of Cell and Developmental Biology / Institute of Immunology 76 JRG Stem Cell Biology 142 Department of Immunology and Rheumatology 78 FLI Institute of Laboratory Animal Science 80 Institute of Farm Animal Genetics 144 Institute of Medical Microbiology and Hospital Epidemiology 82 Institute of Molecular and Cell Physiology 84 Lists of Current HBRS Students 147 Institute of Molecular and Translational Therapeutic Strategies 86 Lists of Alumni 151 Institute of Molecular Biology 88 Imprint 156 | Anniversary Report HBRS | 3 Vorwort HBRSProf. Dr. med. Dieter Bitter-Suermann Das zweite Element, das die HBRS zum Gesamtkunstwerk 10 Jahre strukturierte MHH beiträgt, ist die Internationalität, sind die Farbtupfer Doktorandenausbildung fremder Kulturen, die selbstverständliche Kommunikation an der MHH in der Wissenschaftssprache Englisch, die enge Kooperati- on mit dem Helmholtz-Zentrum für Infektionsforschung in Braunschweig in der Graduiertenausbildung, ein wachsen- des Netzwerk von Alumni über die ganze Welt gespannt. Die Krone der Legitimation bekam die HBRS in der ersten Runde der Exzellenzinitiative als eine ausgezeichnete Gra- duiertenschule, als Dach über drei Jahr für Jahr sich erneu- ernde PhD Programme, über zwei sich alle vier bis sechs Jahre abwechselnde nationale und europäische Graduier- tenkollegs der DFG, für zwei assoziierte Masterprogramme und über ein strukturiertes medizinisches Doktorandenpro- Normalerweise werden Kindergeburtstage mit Eintritt der gramm, StrucMed. Pubertät von den Kindern nicht mehr gefeiert, weil sie sich schon erwachsen fühlen. Davon sind wir aber noch drei bis Nun steht in der zweiten Runde der Exzellenzinitiative im vier Jahre entfernt und daher kann man alle Beteiligten mit Frühjahr 2011 die Bewerbung um eine fünfjährige Verlän- Glückwünschen überschütten und mit voller Überzeugung gerung an. Den vielen Dozenten und Doktormüttern und die Spitzenattribute des Lobgesangs benutzen: –vätern, den Betreuungspersonen, der Leitung der HBRS, ihnen allen gebührt ein großes Stück aus der Geburtstags- Unsere Graduiertenschule HBRS gehört zum Besten, was torte. Die mehr als 200 erfolgreichen promovierten Kinder die MHH auf ihren vielen Gebieten von Spitzenleistungen aber werden als bunte Geburtstagsluftballons und damit zu bieten hat. Sie ist ein zentrales Element unserer struk- als Botschafter über den Globus fliegen und die Marke MHH turierten Nachwuchsförderung vor allem im naturwissen- als einer Spitzenuniversität in der Medizin verbreiten. schaftlichen Bereich der Forschung und damit sind die Gra- duierten sowohl für die Grundlagenforschung wie auch für Hannover, im Oktober 2010 die translationale Forschung in die Klinik hinein mit ihrem nach drei bis vier Jahren erworbenen Dr. rer. nat. oder PhD eine immer sprudelnde Quelle für neue Ideen, ungebremste Neugier und Tatendrang. Kurz, sie verkörpern einen Teil un- Prof. Dr. med. Dieter Bitter-Suermann serer Zukunft. Präsident der MHH 4 | Jubiläumsbericht HBRS | Foreword The second element by which HBRS contributes to the “uni- 10 Years of Structured versal artwork” MHH is the internationality. This is clearly Doctoral Education demonstrated by the multitude of foreign cultures, the usa- at MHH ge of the natural language of science “English”, the strong cooperation in graduate training with the Helmholtz Centre for Infection Research in Braunschweig, and a vastly
Recommended publications
  • Differential Synergy of Notch and T Cell Receptor Signaling Determines Αβ
    ARTICLE Diff erential synergy of Notch and T cell receptor signaling determines αβ versus γδ lineage fate Annette I. Garbe,1 Andreas Krueger,1 Fotini Gounari,1,2 Juan Carlos Zúñiga-Pfl ücker,3 and Harald von Boehmer1 1Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115 2Tufts-New England Medical Center, Boston, MA 02111 3University of Toronto, Toronto, Ontario, M4N 3M5 Canada Thymic precursors expressing the pre–T cell receptor (TCR), the TCR, or the TCR can all enter the CD4+8+ lineage, albeit with different effi cacy. Here it is shown that proliferation and differentiation of precursors with the different TCRs into lineage cells require Notch signaling at the DN3 stage of thymic development. At the DN4 stage, Notch signaling still signifi cantly contributes to the generation of T cells. In particular, in lineage commitment, the pre-TCR synergizes more effi ciently with Notch signals than the other two TCRs, whereas TCR-expressing cells can survive and expand in the absence of Notch signals, even though Notch signaling enhances their proliferation. These observations suggest a new model of versus lineage choice in which lineage fate is determined by the extent of synergy between TCR and Notch signaling and in which the evolutionarily recent advent of the cell-autonomously signaling pre-TCR increased the effi cacy of T cell generation. CORRESPONDENCE The mammalian immune system contains sev- essential for the rescue of DP cells from pro- Harald von Boehmer: eral T lymphocyte lineages of which the grammed cell
    [Show full text]
  • Deciphering Thymic Development
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE OPINION ARTICLE published: 08provided October by 2014 Frontiers - Publisher Connector doi: 10.3389/fimmu.2014.00424 Deciphering thymic development Harald Von Boehmer 1,2* 1 Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA, USA 2 Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, MA, USA *Correspondence: [email protected] Edited by: Kendall A. Smith, Weill Medical College of Cornell University, USA Reviewed by: Herman Waldmann, University of Oxford, UK Keywords: MHC-restricted antigen recognition, T cell clones, TCR alpha/beta cDNA clones, HY antigen, TCR transgenic mice, negative thymic selection, positive thymic selection In 1979, some of us were surprised by beta genes from one T cell clone to asked Hans Georg Rammensee who was the (1) conclusion of Doherty and Zinker- another allowed us to unequivocally con- in the same office a related question. I nagel on MHC-restricted antigen recogni- clude that the MHC-restricted specificity leave it to the audience to imagine what tion following the lead of Katz, Hamaoka, was encoded by a single receptor long Michael Steinmetz told Georges Koehler and Benacerraf (2) describing the same before crystallographic studies reached or better what he did not tell him, even for the interaction of T helper cells with the same conclusion (5). This surprised though one cannot be completely sure of B cells as well as Rosenthal and Shevach some molecular biologists somewhat who it. So Georges did not produce the mice (3) describing it for the interaction of T thought that the cloning of the TCR put but Anton Berns in Amsterdam cooper- cells with macrophages.
    [Show full text]
  • Table of Contents
    Cancer Immunology Research Table of Contents July 2014 Volume 2 Issue 7 EDITORIAL RESEARCH ARTICLES 591 Cancer Immunology Research: A One-Year 616 Immunotherapy Converts Nonimmunogenic Anniversary Pancreatic Tumors into Immunogenic Foci of Immune Regulation Eric R. Lutz, Annie A. Wu, Elaine Bigelow, Rajni Sharma, Guanglan Mo, Kevin Soares, Sara Solt, MASTERS OF IMMUNOLOGY Alvin Dorman, Anthony Wamwea, Allison Yager, Daniel Laheru, Christopher L. Wolfgang, 592 The Thymus in Immunity and in Malignancy Jiang Wang, Ralph H. Hruban, Robert A. Anders, Harald von Boehmer Elizabeth M. Jaffee, and Lei Zheng Synopsis: Lutz and colleagues show that an allogeneic vaccine given with or without low-dose cyclophosphamide converted pancreatic cancer into an immunogenic cancer CANCER IMMUNOLOGY AT THE with infiltrating effector lymphocytes and formation of CROSSROADS: EXPERIMENTAL tertiary lymphoid aggregates that are regulatory structures IMMUNOTHERAPIES of adaptive immunity. 632 598 Hostile, Hypoxia–A2-Adenosinergic Tumor Bevacizumab plus Ipilimumab in Patients with Biology as the Next Barrier to Overcome for Metastatic Melanoma Tumor Immunologists F. Stephen Hodi, Donald Lawrence, Cecilia Lezcano, Xinqi Wu, Jun Zhou, Tetsuro Sasada, Wanyong Zeng, Michail V. Sitkovsky, Stephen Hatfield, Anita Giobbie-Hurder, Michael B. Atkins, Robert Abbott, Bryan Belikoff, Dmitriy Lukashev, Nageatte Ibrahim, Philip Friedlander, and Akio Ohta Keith T. Flaherty, George F. Murphy, Scott Rodig, Elsa F. Velazquez, Martin C. Mihm Jr, Sara Russell, MILESTONES IN CANCER
    [Show full text]
  • April 8, 1997, NIH Record, Vol. XLIX, No. 7
    C 0 R a Still The Second Best Thing About Payday Record Debuts on the Web HIGHLIGHTS· From 'Whatchamacallit' to Funshine New Camp Starts for Children The NIH Record, exclusively a paper publication since May 1949, is now Special love Infected with HIV available electronically on the World Wide launches New By Rich McManus Web. It can be accessed within the NIH Camp home page (www.nih.gov) under the nless you just came to NIH a week ago, you probably know at " Information for Employees" and "News Microsoft least something about Camp Fantastic. For the uninitiated, it's and Events" sections. Or open the site Wunderkind ~ a week-long slice of August turned into terrific summer camp directly by going to http://www.nih.gov/ Foretells Future for children-many of them Clinical Center patients-with cancer, news/NIH-Record/archives.htm. and has always been powered by the freehearted and funloving Catch the Record side of the National Cancer Institute-its Pediatric Branch and The Web version is modeled after the on the Web associated caregivers. It began 15 years ago at a 4-H campground paper one and closely resembles it, but has near Front Royal, Va., and has evolved into a year-round, family­ the advantage of color design and centered program that worries not just about the child with photography. The site's opening page is an cancer, but also about the healthy sibling who wonders where all " Archives" of issues that leads off-for the Dyer, Gorgas Talks of mom and dad's attention went.
    [Show full text]
  • Shaping the T Cell Repertoire
    Shaping the T Cell Repertoire Harald von Boehmer J Immunol 2005; 175:7067-7068; ; This information is current as doi: 10.4049/jimmunol.175.11.7067 of September 27, 2021. http://www.jimmunol.org/content/175/11/7067 Downloaded from References This article cites 6 articles, 3 of which you can access for free at: http://www.jimmunol.org/content/175/11/7067.full#ref-list-1 Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average by guest on September 27, 2021 Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts Errata An erratum has been published regarding this article. Please see next page or: /content/176/1/677.1.full.pdf /content/176/1/677.2.full.pdf The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2005 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Shaping the T Cell Repertoire Harald von Boehmer1 Today immunologists are well aware of positive to self. In this hypothesis, the focus on self-MHC was imposed and negative selection of developing T cells.
    [Show full text]
  • Harald Von Boehmer 1942–2018
    obituary Harald von Boehmer 1942–2018 oday, few topics in immunology Notch family of signaling receptors in this receive more attention than efforts malignancy. With colleagues in the lab, Tto detect, induce or reinvigorate the Harald also published important insights immune response to tumors. Although into the mechanisms through which many types of immune cells affect different T cell populations respond to and contribute to anti-tumor immune tumors and destroy pancreatic β -cells. At responses, the initial clinical findings that the same time, he never stopped pursuing electrified the field focused on the T cell. knowledge of the basic mechanisms that Cancer biologists who grabbed the nearest affect T cell development. While in Boston, immunology textbook in an effort to fully his lab described mechanisms that affect comprehend and build upon those initial the development of regulatory T cells in the clinical successes will have quickly realized thymus and the periphery and continued that at their core, such approaches rely on to publish insights into the structure and understanding how T cells recognize and function of the pre-TCR. respond to antigen. What they may not After closing his Boston lab, Harald have realized is how important Harald returned to his alma mater as a guest von Boehmer’s work was in laying the professor at the Institute for Immunology foundation for this understanding. of the Ludwig Maximilian University in Long before translational research was Munich. In his writings during this period, all the rage, Harald charged a segment of between the TCR and peptide–major Harald expressed optimism about the future his lab with investigating how fundamental histocompatibility complex determined of immunological research.
    [Show full text]
  • Deciphering Thymic Development
    Deciphering Thymic Development The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Von Boehmer, Harald. 2014. “Deciphering Thymic Development.” Frontiers in Immunology 5 (1): 424. doi:10.3389/fimmu.2014.00424. http://dx.doi.org/10.3389/fimmu.2014.00424. Published Version doi:10.3389/fimmu.2014.00424 Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:13347532 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA OPINION ARTICLE published: 08 October 2014 doi: 10.3389/fimmu.2014.00424 Deciphering thymic development Harald Von Boehmer 1,2* 1 Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA, USA 2 Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, MA, USA *Correspondence: [email protected] Edited by: Kendall A. Smith, Weill Medical College of Cornell University, USA Reviewed by: Herman Waldmann, University of Oxford, UK Keywords: MHC-restricted antigen recognition, T cell clones, TCR alpha/beta cDNA clones, HY antigen, TCR transgenic mice, negative thymic selection, positive thymic selection In 1979, some of us were surprised by beta genes from one T cell clone to asked Hans Georg Rammensee who was the (1) conclusion of Doherty and Zinker- another allowed us to unequivocally con- in the same office a related question. I nagel on MHC-restricted antigen recogni- clude that the MHC-restricted specificity leave it to the audience to imagine what tion following the lead of Katz, Hamaoka, was encoded by a single receptor long Michael Steinmetz told Georges Koehler and Benacerraf (2) describing the same before crystallographic studies reached or better what he did not tell him, even for the interaction of T helper cells with the same conclusion (5).
    [Show full text]
  • The Henry Kunkel Society Annual Meeting: Infectious Disease Susceptibility and the Expanding Universe of Primary Immunodeficiency
    The Henry Kunkel Society Annual Meeting: Infectious Disease Susceptibility and the Expanding Universe of Primary Immunodeficiency The Rockefeller University New York, NY April 17–20, 2013 Henry George Kunkel 1916–1983 enry Kunkel received his B.S. degree from Princeton and his M.D. degree from Johns Hopkins University. He arrived at The Rockefeller Institute (now University) in 1945 where he spent his entire scientific career H until his death in 1983. His contributions to the field of basic and clinical immunology are legendary. He made numerous seminal observations in liver disease, rheumatic diseases and other allied disorders. He was perhaps best known for his pioneering and extensive studies on the immunoglobulins. His recognition that myeloma proteins were a model for the study of the structure of normal immunoglobulins had a global impact on investigations of the structure, function and inheritance of these molecules. The elucidation of the chain structure of gamma globulin and the recognition that immunoglobulins possessed individual antigenic specificity (idiotypes) were internationally recognized discoveries. Dr. Kunkel was the recipient of many awards and honors, including membership in the National Academy of Sciences, honorary degrees from Universities of Uppsala and Harvard, and recipient of the Lasker and Gairdner Awards and the Kovalenko Medal of the National Academy of Sciences. Henry Kunkel Society Officers Henry Kunkel Society Lecturers President ................Westley Reeves 1992. Louis Kunkel 2003. .Fred Rosen Vice President ...............Keith Elkon 1993. .David Ho 2004. .Diane Mathis Secretary ........... Michel Nussenzweig 1994. Benvenuto Pernis 2005. Charles Weissman Treasurer ...............Anne Marshak- 1996. Jeffrey Ravetch 2006. Ralph M. Steinman Rothstein 1997. Anthony Fauci 2007.
    [Show full text]
  • The Paul Ehrlich Foundation
    The Paul Ehrlich Foundation Office of the Paul Ehrlich Foundation Contents Paul Ehrlich-Stiftung c/o Vereinigung von Freunden und Förderern der Goethe-Universität Theodor-W.-Adorno-Platz 1 Preface 5 60629 Frankfurt am Main E-Mail: [email protected] www.paul-ehrlich-stiftung.de Paul Ehrlich: His Life March 2021 and Achievements 6 Ludwig Darmstaedter: Donation account: Scientist and Friend 12 Deutsche Bank AG IBAN: DE38 5007 0010 0700 0839 00 BIC: DEUTDEFFXXX The Foundation, the Prize and the Role of Hedwig Ehrlich 14 The Paul Ehrlich and Ludwig Darmstaedter Prize for Young Researchers 17 Preface In honor of the great German doctor and Paul Ehrlich, like all great researchers, was serologist who turned Frankfurt into a way ahead of his time. His research work medical eldorado at the beginning of the laid the cornerstone for the medical stand- 20th century, the Paul Ehrlich and Ludwig ards still valid today. In awarding the Paul Darmstaedter Prize is awarded to scientists Ehrlich and Ludwig Darmstaedter Prize, the from all over the world who have achieved Foundation wishes to encourage scientists all outstanding results in Paul Ehrlich’s field over the world to do what Paul Ehrlich did of work. throughout his entire life: extend medical know-how and make a contribution to the The prize given by the Paul Ehrlich constant struggle against illness and disease- Foundation is one of Germany’s most emi- induced mortality. nent accolades in recognition of outstand- ing achievements in biomedical research. The President of the German Research Foundation (DFG) is Honorary President of the Paul Ehrlich Foundation.
    [Show full text]
  • Immunology in Germany German Society for Immunology
    1901 1984 Emil von Behring Georges J.F. Köhler Nobelprize ‘for his work on serum Nobelprize therapy, especially its ‘for theories application against concerning the diphtheria, by which specificity in 2008 he has opened a new 1905 development and Harald zur road in the domain of Robert Koch control of the Hausen medical science and 1908 immune system thereby placed in the Nobelprize Paul Ehrlich and the discovery Nobelprize hands of the physician ‘for his investigations of the principle ‘for his discovery of a victorious weapon and discoveries in Nobelprize for production human papilloma against illness and relation to ‘in recognition of his of monoclonal viruses causing deaths’ tuberculosis’ work on immunity’ antibodies’ cervical cancer’ Immunology in Germany German Society for Immunology Content Preface ............................................................................... 3 About the DGfI ...................................................................4 Academy of Immunology ...................................................6 Research Focus Groups ......................................................7 Scientific Awards ................................................................8 Annual Meeting ...............................................................10 International Networks & Bilateral Meetings ..................11 Immunology in Germany - Overview ..............................12 Public Outreach - ‚Immunology for Everyone‘ ................16 Membership in the DGfI? Yes! .........................................17
    [Show full text]
  • How Does the Immune System Learn to Distinguish Between Good and Evil? the First Definitive Studies of T Cell Central Tolerance and Positive Selection
    Immunogenetics (2019) 71:513–518 https://doi.org/10.1007/s00251-019-01127-8 REVIEW How does the immune system learn to distinguish between good and evil? The first definitive studies of T cell central tolerance and positive selection Paweł Kisielow1 Received: 30 July 2019 /Accepted: 3 August 2019/Published online: 15 August 2019 # The Author(s) 2019 Abstract Demonstration that immature CD4 + 8+ thymocytes contain T cell precursors that are subjected to positive and negative selection was the major step towards understanding how the adaptive immune system acquires the ability to distinguish foreign or abnormal (mutated or infected) self-cells from normal (healthy) cells. In the present review, the roles of TCR, CD4, CD8, and MHC molecules in intrathymic selection and some of the crucial experiments that contributed to the solution of the great immunological puzzle of self/ nonself discrimination are described in an historical perspective. Recently, these experiments were highlighted by the immunological community by awarding the 2016 Novartis Prize for Immunology to Philippa Marrack, John Kappler, and Harald von Boehmer. Keywords Tcells . Positive and negative selection . Self/nonself discrimination Introduction 1959; Peter Medawar, 1960; Gerald Edelman and Roney Porter, 1972; Baruj Benaceraff, Jean Dausset, and George The “Good” that is protected by the immune system consists Snell, 1983; Niels Jerne, George Koehler, and Cesar Milstein of properly functioning healthy cells, and the “Evil” that is 1984; Susumu Tonegawa, 1987; Peter Doherty
    [Show full text]
  • Table of Contents (PDF)
    Cancer Immunology Research Table of Contents July 2014 Volume 2 Issue 7 EDITORIAL RESEARCH ARTICLES 591 Cancer Immunology Research: A One-Year 616 Immunotherapy Converts Nonimmunogenic Anniversary Pancreatic Tumors into Immunogenic Foci of Immune Regulation Eric R. Lutz, Annie A. Wu, Elaine Bigelow, Rajni Sharma, Guanglan Mo, Kevin Soares, Sara Solt, MASTERS OF IMMUNOLOGY Alvin Dorman, Anthony Wamwea, Allison Yager, Daniel Laheru, Christopher L. Wolfgang, 592 The Thymus in Immunity and in Malignancy Jiang Wang, Ralph H. Hruban, Robert A. Anders, Harald von Boehmer Elizabeth M. Jaffee, and Lei Zheng Synopsis: Lutz and colleagues show that an allogeneic vaccine given with or without low-dose cyclophosphamide converted pancreatic cancer into an immunogenic cancer CANCER IMMUNOLOGY AT THE with infiltrating effector lymphocytes and formation of CROSSROADS: EXPERIMENTAL tertiary lymphoid aggregates that are regulatory structures IMMUNOTHERAPIES of adaptive immunity. 632 598 Hostile, Hypoxia–A2-Adenosinergic Tumor Bevacizumab plus Ipilimumab in Patients with Biology as the Next Barrier to Overcome for Metastatic Melanoma Tumor Immunologists F. Stephen Hodi, Donald Lawrence, Cecilia Lezcano, Xinqi Wu, Jun Zhou, Tetsuro Sasada, Wanyong Zeng, Michail V. Sitkovsky, Stephen Hatfield, Anita Giobbie-Hurder, Michael B. Atkins, Robert Abbott, Bryan Belikoff, Dmitriy Lukashev, Nageatte Ibrahim, Philip Friedlander, and Akio Ohta Keith T. Flaherty, George F. Murphy, Scott Rodig, Elsa F. Velazquez, Martin C. Mihm Jr, Sara Russell, MILESTONES IN CANCER
    [Show full text]